数字医疗保健技术在癌症治疗途径中的作用——基于英国的调查结果
The Role of Digital Healthcare Technology Within the Cancer Treatment Pathway - Results From a UK-Based Survey.
摘要(中文译文)
数字技术在肿瘤诊疗中的应用，包括智能手表、可穿戴传感器和基于应用程序的平台，能够实现持续的实时健康监测。然而，许多设备是为健身或健康市场设计的，并未针对肿瘤患者的临床监测进行优化。本调查探讨了数字技术在肿瘤诊疗全程中的潜在作用，并旨在识别应用推广的关键障碍。通过专家共识开发了一份网络问卷，经内部验证后在五名个体中进行了预试验。问卷通过专业网络和社交媒体分发至英国医疗专业人员和学者。调查考察了：（1）数字技术在治疗前、治疗中和治疗后的作用；（2）技术障碍；（3）人为因素。定量数据采用描述性分析，自由文本回答采用主题分析。共收到84份回复（包括28%联合医疗科学家、26%护士、9%临床医生）。48%的受访者曾在研究中使用数字技术，27%在直接临床诊疗中使用。大多数受访者（95%）认为数字技术可通过与临床团队直接沟通（94%）、情绪监测（91%）和生命体征监测（87%）使肿瘤患者获益。感知获益在肿瘤诊疗全程中有所不同：治疗前，提供对患者健康状况的洞察（91%）；治疗中，监测生命体征（96%）和副作用（91%）；治疗后，支持康复（94%）。技术障碍包括与临床系统整合不佳（66%）、互操作性有限（83%）、对数据准确性的担忧（82%）以及用户设计欠佳（80%）。人为因素包括需要长期支持（94%）和数字素养（92%）。专科团队被认为最适合在前瞻性研究中主导监测（77%），初级保健适合长期随访（53%），患者在这两种场景中均发挥核心作用。数字技术被视为贯穿肿瘤诊疗全程的有价值工具，但如今必须解决整合、互操作性、设计和人为因素方面的问题，以实现有效且公平的临床采纳。
Abstract
Digital technologies in cancer care, including smartwatches, wearable sensors, and app-based platforms, enable continuous real-time health monitoring. However, many devices are designed for fitness or wellness markets and are not optimised for clinical monitoring of cancer patients. This survey explored the potential role of digital technologies across the cancer pathway and aimed to identify key barriers to adoption. A web-based questionnaire was developed through expert consensus, internally validated, and piloted with five individuals. It was distributed to UK-based healthcare professionals and academics via professional networks and social media. The survey examined: (1) the role of digital technology before, during, and after treatment; (2) technical barriers; and (3) human factors. Quantitative data were analysed descriptively and free-text responses thematically. Eighty-four responses were received (including 28% allied healthcare scientists, 26% nurses, 9% clinicians). 48% had used digital technologies in research and 27% in direct clinical care. Most respondents (95%) believed digital technologies could benefit cancer patients through direct communication with clinical teams (94%), mood monitoring (91%), and vital sign monitoring (87%). Perceived benefits varied across the cancer care pathway: before treatment, providing insight into patients' health (91%); during treatment, monitoring vital signs (96%) and side effects (91%); and after treatment, supporting rehabilitation (94%). Technical barriers included poor integration into clinical systems (66%), limited interoperability (83%), data accuracy concerns (82%), and suboptimal user design (80%). Human factors included the need for long-term support (94%) and digital literacy (92%). Specialist teams were considered most appropriate leads for monitoring during prospective studies (77%) and primary care for long-term follow-up (53%), with patients playing a central role in both scenarios. Digital technologies are viewed as valuable tools across the cancer pathway, but integration, interoperability, design, and human factors must now be addressed to enable effective and equitable clinical adoption.
如何引用
AMA
A McWilliam, M Aznar, K Banfill, A Birtle, S Ingram, G Kitchen, et al. The Role of Digital Healthcare Technology Within the Cancer Treatment Pathway - Results From a UK-Based Survey.. Clinical oncology (Royal College of Radiologists (Great Britain)). 2026; doi:10.1016/j.clon.2026.104297.
APA
A McWilliam, M Aznar, K Banfill, A Birtle, S Ingram, G Kitchen, et al (2026). The Role of Digital Healthcare Technology Within the Cancer Treatment Pathway - Results From a UK-Based Survey.. Clinical oncology (Royal College of Radiologists (Great Britain)). https://doi.org/10.1016/j.clon.2026.104297
GB/T 7714
A McWilliam, M Aznar, K Banfill, A Birtle, S Ingram, G Kitchen, et al. The Role of Digital Healthcare Technology Within the Cancer Treatment Pathway - Results From a UK-Based Survey.[J]. Clinical oncology (Royal College of Radiologists (Great Britain)), 2026 doi:10.1016/j.clon.2026.104297.
在 PubMed增强版 阅读全文
翻译全文 · AI 文献问答 · PDF 原文下载 · 引用导出